P. Gøtzsche

Statistics and Probability · 2000–2024

A researcher in the Science corpus: 22 papers; trusts 14 researchers and is trusted by 31 researchers here, as inferred from the citation graph.

Subfields

• Statistics and Probability — 231 citations into it; #2,072 of 12,932 by trust here, #83 by citations
• Economics and Econometrics — 119 citations into it; #11,251 of 23,481 by trust here, #1,633 by citations
• General Health Professions — 73 citations into it; #2,818 of 4,781 by trust here, #60 by citations
• Public Health, Environmental and Occupational Health — 66 citations into it; #868 of 2,368 by trust here, #227 by citations
• Sociology and Political Science — 24 citations into it; #5,637 of 22,756 by trust here, #709 by citations
• Oncology — 10 citations into it; #1,113 of 1,698 by trust here, #1,123 by citations
• Genetics — 5 citations into it

Whom P. Gøtzsche trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Douglas G. Altman
2. David Moher
3. K. F. Schulz
4. Julian P. T. Higgins
5. Peter Jüni
6. Sander Greenland
7. John P. A. Ioannidis
8. Diana Elbourne
9. Matthias Egger
10. A. Chan

Who trusts P. Gøtzsche overall

1. Douglas G. Altman
2. David Moher
3. John P. A. Ioannidis
4. K. F. Schulz
5. Lifeng Lin
6. Jan Derks
7. Gary S. Collins
8. Ted J. Kaptchuk
9. Daniele Fanelli
10. Matthew J. Page

Papers from P. Gøtzsche's perspective

Ordered by how strongly the researchers P. Gøtzsche trusts endorse each paper. Same corpus, a different order for every researcher.

1. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (British medical journal)
2. Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias (PLoS ONE)
3. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review (Medical Journal of Australia)
4. Principles of multilevel modelling. (International Journal of Epidemiology)
5. Vasopressin versus norepinephrine infusion in patients with septic shock. (New England Journal of Medicine)
6. Optimal medical therapy with or without PCI for stable coronary disease. (New England Journal of Medicine)
7. Statistical considerations in the intent-to-treat principle. (Controlled Clinical Trials)
8. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. (New England Journal of Medicine)
9. Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates (New England Journal of Medicine)
10. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. (The Lancet)

Their papers

• Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. (2004) — 1,810 citations
• CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010) — 6,841 citations
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009) — 37,422 citations
• Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007) — 9,533 citations
• CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. (2012) — 3,604 citations
• SPIRIT 2013 statement: defining standard protocol items for clinical trials. (2013) — 6,010 citations
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. (2007) — 9,582 citations
• PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts (2013) — 611 citations
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. (2007) — 6,189 citations
• SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials (2013) — 5,077 citations
• Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. (2007) — 2,675 citations
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007) — 11,147 citations
• Screening for breast cancer with mammography (2024) — 1,399 citations
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. (2014) — 4,890 citations
• Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2014) — 11,185 citations
• Research: increasing value, reducing waste 4 Increasing value and reducing waste: addressing inaccessible research (2014) — 722 citations
• [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]. (2008) — 2,135 citations
• ORIGINAL ARTICLES The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (2008) — 7,114 citations
• Placebo interventions for all clinical conditions. (2004) — 598 citations
• Cochrane review on screening for breast cancer with mammography. (2001) — 741 citations